CTOs on the Move

Concert Pharmaceuticals

www.concertpharma.com

 
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs. The Company`s approach starts with previously studied compounds, including approved drugs, in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert has a broad pipeline of innovative medicines targeting autoimmune and inflammatory diseases and central nervous systems (CNS) disorders.
  • Number of Employees: 100-250
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Funding

Concert Pharmaceuticals raised $30M on 06/12/2017
Concert Pharmaceuticals raised $66.4M on 06/01/2022

Similar Companies

Pharmachem Labs

Pharmachem Laboratories, Inc., is a leading manufacturer and supplier of value-added nutritional ingredients and bulk raw materials. We offer an exclusive list of trademarks and catalogue of products, as well as custom-manufacturing, and research and

CROWDHEALTH

One of the leading health care sources in the nation. We offer certified, medical grade supplies worldwide. info@crowdhealth.org

ReCept Pharmacy

ReCept Pharmacy is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elevation Pharmaceuticals

Elevation Pharmaceuticals is a biopharmaceutical company focused on developing new inhaled therapies for patients with respiratory disease.

BioCareSD

BioCareSD is a specialty distributor of biological products for hemophilia, thrombophilia, immunology, critical care, and ALS. They are committed to providing customer-oriented solutions, unmatched service levels, and a unique distribution network to e...